Literature DB >> 9554519

Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma.

S T Tsai1, Y T Jin, R B Mann, R F Ambinder.   

Abstract

BACKGROUND: Nasopharyngeal carcinoma (NPC) is strongly associated with Epstein-Barr virus (EBV). Detection of EBV in biopsy specimens may serve as a tumor marker.
METHODS: To assess the sensitivity and specificity of the polymerase chain reaction (PCR) and in situ hybridization in the diagnosis of NPC, formalin fixed, paraffin embedded nasopharyngeal biopsies from patients in Taiwan suspected of having NPC were studied.
RESULTS: In specimens from 107 patients with NPC, EBV was detected by PCR in 97 cases (90.7%) and by EBER in situ hybridization in 105 cases (98.1%). In specimens from 61 patients without neoplasia, EBV was detected by PCR in 7 cases (11.5%) and by EBER in situ hybridization in 0 cases.
CONCLUSIONS: These results suggest that although EBV DNA may occasionally be detected in nonneoplastic nasopharyngeal tissues, cells expressing EBER are not. EBER in situ hybridization may therefore prove to be a useful adjunct in the diagnosis of NPC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9554519

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

Review 1.  Does East meet West? Towards a unified vision of the management of Nasopharyngeal carcinoma.

Authors:  Elaine Johanna Limkin; Pierre Blanchard
Journal:  Br J Radiol       Date:  2019-05-31       Impact factor: 3.039

Review 2.  Virus-associated neoplasms of the nasopharynx and sinonasal tract: diagnostic problems.

Authors:  John Kc Chan
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

3.  The incidence of Epstein-Barr virus in nasopharyngeal carcinoma of Jordanian patients.

Authors:  Ismail Matalka; Mohammad Al Hamad; Maysa Al-Hussaini; Firas Q Alzoubi
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-03-16       Impact factor: 2.503

4.  Human papillomavirus and WHO type I nasopharyngeal carcinoma.

Authors:  Emily J Lo; Diana Bell; Jason S Woo; Guojun Li; Ehab Y Hanna; Adel K El-Naggar; Erich M Sturgis
Journal:  Laryngoscope       Date:  2010-10       Impact factor: 3.325

5.  Expression of Epstein-Barr-virus-encoded small nuclear RNA in nasopharyngeal carcinomas of Aegean Turkish patients.

Authors:  Yeşim Ertan; Mine Hekimgil; Serap Karaarslan; Saliha Soydan
Journal:  Virchows Arch       Date:  2008-02-26       Impact factor: 4.064

6.  Formation of 8-nitroguanine, a nitrative DNA lesion, in inflammation-related carcinogenesis and its significance.

Authors:  Yusuke Hiraku
Journal:  Environ Health Prev Med       Date:  2009-11-19       Impact factor: 3.674

7.  Prevalence and relevance of EBV latency in nasopharyngeal carcinoma in Israel.

Authors:  G Bar-Sela; A Kuten; I Minkov; E Gov-Ari; O Ben-Izhak
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

Review 8.  Viral non-coding RNAs: Stealth strategies in the tug-of-war between humans and herpesviruses.

Authors:  Takanobu Tagawa; Anna Serquiña; Insun Kook; Joseph Ziegelbauer
Journal:  Semin Cell Dev Biol       Date:  2020-07-03       Impact factor: 7.727

9.  A primary nasopharyngeal three-dimensional air-liquid interface cell culture model of the pseudostratified epithelium reveals differential donor- and cell type-specific susceptibility to Epstein-Barr virus infection.

Authors:  Phillip Ziegler; Yarong Tian; Yulong Bai; Sanna Abrahamsson; Alan Bäckerholm; Alex S Reznik; Anthony Green; John A Moore; Stella E Lee; Michael M Myerburg; Hyun Jung Park; Ka-Wei Tang; Kathy Ho Yen Shair
Journal:  PLoS Pathog       Date:  2021-04-29       Impact factor: 6.823

10.  Head and neck cancer. An aetiopathogenetic study of non-endemic lymphoepithelioma.

Authors:  F G Casco; M J Ríos; M DE Miguel; T González; A M Moreno Fernández; H Galera-Ruiz; R González-Cámpora; R Drut; C Bacchi; H Galera-Davidson
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-02       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.